CHRN · ChronoScale Holdings Corp
$20.06
-0.02 (-0.10%)
At close · Sep 4
Going-concern doubt
— cleared Aug 19, 2026
The latest filing no longer states the doubt (first flagged Apr 28, 2026).
View the 10-K filed Aug 19, 2026Market Cap
$2.77B
Shares
145.64M
CHRN metrics
65 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$20.08
Market cap
$2.77B
Price action
19 metricsPrice change (1W)
-10.1%
Price change (30D)
-22.2%
Price change (3M)
-0.2%
Price change (6M)
+78.3%
Price change (YTD)
+120.0%
Price change (1Y)
+381.3%
Trailing year
Price change (5Y)
—
52-week high
$29.63
52-week low
$3.83
Change from 52-week high
-35.8%
Change from 52-week low
+396.3%
Annualized volatility
142.0%
Beta
2.9
RSI (14D)
42.7
Price vs SMA 50
-12.2%
Price vs SMA 200
+41.3%
Avg volume (3M)
301,312
Relative volume
0.4
Average dollar volume
$6.51M
Company
3 metricsSector
Technology
Industry
Information Technology Services
Shares outstanding
145.64M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
239.4×
reciprocal yield 0.4%
P / book
15.4
reciprocal yield 6.5%
FCF yield
-0.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-0.6%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.9×
reciprocal yield 116.0%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 85.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-02-17
Profitability
9 metricsGross margin
52.9%
Operating margin
-134.1%
Trailing 12 months
Net margin
-135.7%
Gross profit (TTM)
$6.11M
Operating profit (TTM)
−$15.50M
Net income (TTM)
−$15.69M
Trailing 12 months
Diluted EPS (TTM)
$-5.11
FCF margin
-104.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-36.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$11.56M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+44.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-750.7%
Return on assets
-79.8%
Debt / equity
0.0
Current ratio
0.5
EBITDA (TTM)
−$13.86M
Free cash flow (TTM)
−$12.14M
Quick ratio
—
Interest coverage
-40.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$5.82M
Latest balance sheet
Cash & equivalents
$9.66M
Total assets
$325.87M
Total debt
$3.84M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$11.96M
Capital expenditures (TTM)
$178,000
R&D (TTM)
$2.63M
SG&A (TTM)
—
Stock compensation (TTM)
$1.34M
R&D / revenue
22.7%
Stock compensation / revenue
11.6%
Ownership (13F)
3 metrics13F filers
45
13F filer change QoQ
+13
Institutional ownership
0.7%
Short interest
3 metricsShort interest
0.4%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
44 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1549084
CUSIP
170924104
13F (30d)
36 filings
36 filers
Visit website
Investor relations